Close

Dr. Reddys launches Heartburn Drug in the US

Note* - All images used are for editorial and illustrative purposes only and may not originate from the original news provider or associated company.

Related stories

Buying Guide: How to Source High-Quality Selank for Research

Peptide research continues to expand across academic and independent...

CSPC Pharmaceutical and AstraZeneca form Biologics Joint Venture

CSPC Pharmaceutical and AstraZeneca have signed a joint venture...

Bristol Myers Squibb Expands Strategic AI Partnership with Schrรถdinger

Bristol Myers Squibb has expanded its ongoing strategic partnership...
- Advertisement -

Dr. Reddyโ€™s has launched over-the-counter Heartburn drug called Lansoprazole delayed-release capsules in the US Market. The company has come up with these capsules in the strength of 15 mg. as approved by the US FDA. These capsules can be used to treat frequent heartburn that occurs two or three days in a week.

As per the statement released by the company, they are pleased to continue to expand their antacids and PPI portfolio for the customers. The companyโ€™s product is equivalent to Takeda Pharmaceuticals North America Incโ€™s Prevacid 24HR capsules.

 

Never miss a pharmaceutical headline

The pharmaceutical industry moves fast โ€“ stay on top of it with our must - read briefings.

  • The top pharma and life sciences stories, straight to your inbox
  • The biggest news, features, interviews, and analysis
  • Dedicated coverage of the key developments driving the global pharmaceutical sector

Subscribe

- Never miss a story with notifications

- Gain full access to our premium content

- Browse free from any location or device.

Media Packs

Expand Your Reach With Our Customized Solutions Empowering Your Campaigns To Maximize Your Reach & Drive Real Results!

โ€“ Access the Media Pack Now

โ€“ Book a Conference Call

โ€“ Leave Message for Us to Get Back

Latest stories

Related stories

Buying Guide: How to Source High-Quality Selank for Research

Peptide research continues to expand across academic and independent...

CSPC Pharmaceutical and AstraZeneca form Biologics Joint Venture

CSPC Pharmaceutical and AstraZeneca have signed a joint venture...

Bristol Myers Squibb Expands Strategic AI Partnership with Schrรถdinger

Bristol Myers Squibb has expanded its ongoing strategic partnership...

O-1A Visa Evidence for Pharma and Biotech Professionals: What Actually Proves Extraordinary Ability

Important pharmaceutical work is not always publicly visible. A medicinal...

Subscribe

- Never miss a story with notifications

- Gain full access to our premium content

- Browse free from any location or device.

Media Packs

Expand Your Reach With Our Customized Solutions Empowering Your Campaigns To Maximize Your Reach & Drive Real Results!

โ€“ Access theMedia Pack Now

โ€“ Book a Conference Call

โ€“ Leave Message for Us to Get Back

Translate ยป